trava glp 1 67 pounds lost. Confidence gained. Habits rebuilt. This is what consistency + support looks like with Health! #travahealth #glp1journey #glp1 #glp1community 1 production Tirzepatide Research Peptide | cGMP

Description

Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin hormone produced primarily by specialised L-cells in the distal small intestine and colon

Each medication follows a unique dose-escalation protocol, starting with a low dose and gradually increasing over several weeks to minimise side effects whilst achieving optimal glycaemic control or weight management

In comparison, other diabetic medications showed a range of 2.3%-6.3% for diabetic retinopathy and 0.05%-0.19% for adverse ocular events

Nauck MA, Meier JJ (2019) Are all GLP-1 agonists equal in the treatment of type 2 diabetes

Targeted placement of dermal fillers in these deflated superficial fat compartments alone or in combination with collagen biostimulators (for moderate-severe changes) can provide immediate volumisation and structural support, with the stimulation of collagen support from the collagen biostimulators